Rivaroxaban

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

PMSCRIVAROXABAN, XARELTO – BAYER INC (NOC Search)

Patents:

2396561: SANDOZ, TEVA, APOTEX, TARO PHARMACEUTICALS, TEVA, SANDOZ, MINT, PHARMASCIENCE, APOTEX, REDDY
2451258: REDDY, TEVA
2547113: SANDOZ, TEVA, TARO PHARMACEUTICALS, APOTEX, TARO PHARMACEUTICALS, REDDY, JAMP, ACCORD HEALTHCARE, PHARMASCIENCE, APOTEX, SANDOZ, APOTEX, TARO PHARMACEUTICALS, TEVA, SANDOZ, TEVA, MINT
2624310: JAMP, SANDOZ, TEVA, TARO PHARMACEUTICALS, APOTEX, TARO PHARMACEUTICALS, REDDY, SANDOZ, APOTEX, TARO PHARMACEUTICALS, TEVA, SANDOZ, TEVA, MINT, ACCORD HEALTHCARE, PHARMASCIENCE, APOTEX
2634310: TEVA
2823159: PHARMASCIENCE, ACCORD HEALTHCARE, APOTEX, MINT, APOTEX, TARO PHARMACEUTICALS, TEVA, SANDOZ, SANDOZ, TEVA, SANDOZ, TEVA, TARO PHARMACEUTICALS, APOTEX, REDDY, TARO PHARMACEUTICALS, JAMP
2993858: REDDY
9415053: APOTEX, TARO PHARMACEUTICALS, TEVA, SANDOZ

ACCORD HEALTHCARE

PM(NOC) – T-1221-19

APOTEX

PM(NOC) – T-2093-18 (2020 FC 325, 2020 FC 866)
Other – 20-A-34

APOTEX, TARO PHARMACEUTICALS, TEVA, SANDOZ

Other – 19-A-65
Appeal – A-15-20 (2020 FCA 72)
PM(NOC) – A-388-19 (2020 FCA 86)

JAMP

PM(NOC) – T-591-20

MINT

PM(NOC) – T-605-20

PHARMASCIENCE

PM(NOC) – T-270-20

REDDY

Infringement – T-1029-21
PM(NOC) – T-1187-19 (2019 FC 1408)

SANDOZ

PM(NOC) – T-806-19

SANDOZ, TEVA, TARO PHARMACEUTICALS, APOTEX

Appeal – A-16-20 (2020 FCA 71)

TARO PHARMACEUTICALS

PM(NOC) – T-435-19

TEVA

PM(NOC) – T-1021-19 – T-1960-18 (2019 FC 191, 2019 FC 1039, 2019 FC 1370)

Return to the Patented Medicine Litigation page.

Canadian Intellectual Property